Global Aquaculture Vaccines Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: July 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Aquaculture Vaccines Market was valued at $480 mn. in 2025. During the forecast period 2025-2030, it is expected to grow at 7.8% CAGR, to an estimated market size of $699 mn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The global aquaculture vaccines market comprises the development, production, and distribution of biological preparations designed to stimulate the immune systems of aquatic animals, primarily finfish and crustaceans. The scope includes inactivated, live attenuated, and DNA-based vaccines used to prevent bacterial, viral, and parasitic infections, serving as a preventive alternative to antibiotic treatments in commercial farming.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Aquaculture Vaccines Market in the period 2025-30:
- The industry is undergoing a structural shift from reactive antibiotic treatments to proactive preventive immunization to combat rising antimicrobial resistance.
- Increasing consumer and regulatory demand for antibiotic-free seafood is forcing producers to adopt vaccination to maintain access to high-value export markets.
- Technological advancements in DNA and mRNA vaccines are enabling faster development cycles and more effective protection against complex viral pathogens.
- The expansion of intensive aquaculture in emerging economies like China and India is driving the need for scalable disease management solutions to protect high-density stocks.
- Development of thermostable formulations is reducing reliance on cold-chain logistics, facilitating vaccine adoption in remote or tropical farming regions.
- Rising water temperatures due to climate change are altering pathogen profiles, necessitating the development of new vaccines for emerging aquatic diseases.
- A growing preference for immersion and oral vaccines is emerging to reduce the labor costs and fish stress associated with traditional manual injection methods.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- Europe
- Asia-Pacific
- North America
- Latin America
- Middle East & Africa
Segments
- Inactivated Vaccines
- Live Attenuated Vaccines
- DNA & Recombinant Vaccines